Julia Berges‐Soria

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

Angelo Gámez‐Pozo, Julia Berges‐Soria, Jorge M. Arevalillo et al. · Cancer Research · 2015 · 68 citations · Full text

Clinical Implications, Unique Metabolic Profile, Engineering +20

Expanding the mutation spectrum in 182 Spanish probands with craniosynostosis: identification and characterization of novel TCF12 variants

Beatriz Paumard‐Hernández, Julia Berges‐Soria, Eva Barroso et al. · European Journal of Human Genetics · 2014 · 64 citations · Full text

Developmental Anomaly, Genetic Disorder, Genetics +9

Functional proteomics outlines the complexity of breast cancer molecular subtypes

Angelo Gámez‐Pozo, Lucía Trilla‐Fuertes, Julia Berges‐Soria et al. · Scientific Reports · 2017 · 55 citations · Full text

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics

Angelo Gámez‐Pozo, Lucía Trilla‐Fuertes, Guillermo Prado-Vázquez et al. · PLoS ONE · 2017 · 34 citations · Full text

The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy

Angelo Gámez‐Pozo, Ramón María Pérez Carrión, Luís Manso et al. · PLoS ONE · 2014 · 26 citations · Full text